CN Patent

CN107405503A — 鞣花酸二水合物在药物制剂中调节血糖水平的用途

Assigned to Halo Life Science LLC · Expires 2017-11-28 · 8y expired

What this patent protects

本发明一般涉及包含有助于增加葡萄糖摄取的鞣花酸二水合物化合物的药物组合物和使用方法。

USPTO Abstract

本发明一般涉及包含有助于增加葡萄糖摄取的鞣花酸二水合物化合物的药物组合物和使用方法。

Drugs covered by this patent

Metro I.V. In Plastic Container (METRONIDAZOLE) · Baxter

Patent Metadata

Patent number: CN107405503A
Jurisdiction: CN
Classification: —
Expires: 2017-11-28
Drug substance claim: No
Drug product claim: No
Assignee: Halo Life Science LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.